32 results
8-K
EX-99.1
Prolung Inc
7 Oct 21
IONIQ Sciences Announces the Appointment of Aaron B. Dorny to its Board of Directors
6:10am
will greatly help us achieve our goals. Mr. Dorny’s contributions to our company over the past year and a half have already increased IONIQ’s market … IONIQ Sciences’ future performance and goals, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995
8-K
EX-99.2
xpehdcf
28 May 20
ProLung announces corporate name change to IONIQ Sciences to reflect expanded early cancer detection strategy
6:05am
8-K
EX-99.1
ry4ys02qop7
28 May 20
ProLung announces corporate name change to IONIQ Sciences to reflect expanded early cancer detection strategy
6:05am
8-K
EX-99.1
furc8ep1ap3v u2cfv
13 Feb 20
ProLung Test™ Granted ‘Breakthrough Device’ Designation by the FDA
5:19pm
8-K
EX-99.1
mmsn07neov
13 Feb 20
Regulation FD Disclosure
12:00am
8-K
EX-99.1
2no8t
26 Nov 19
ProLung Announces Change to its Board of Directors
3:27pm
8-K
EX-99.1
tb1q6 rzp
3 Oct 19
ProLung, Inc. Announces Large Clinical Validation Trial Results of 84% sensitivity and 74% specificity
4:00pm
8-K
EX-99.1
keakp7gjew jp6y932
12 Aug 19
ProLung Announces the Appointment of Leavitt Partners and Mr. Rich
3:00pm
8-K
EX-99.1
y8gzbttgy6q8r2
12 Jun 19
ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise
4:21pm
DEFC14A
mmr6 mzugjn9
19 Nov 18
Proxy in contested solicitation
9:51am
PREC14A
eqcpu bdzujyfr
6 Nov 18
Preliminary proxy with contested solicitation
9:10am
DEFA14A
u0d 2ktnma
2 Oct 18
Additional proxy soliciting materials
5:25pm
8-K
EX-99.1
8yu3yja t4
2 Oct 18
Other Events
5:23pm
DEFA14A
rk80grc
1 Oct 18
Additional proxy soliciting materials
1:28pm
8-K
EX-99.1
4idtq68o 8upgvqig8e
1 Oct 18
Other Events
1:21pm